Melissa F. Adasme
Dresden, SN 01307, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction: Integrating artificial intelligence and manual curation to enhance bioassay annotations in ChEMBL.
Journal: Journal of cheminformatics
Published: March 28, 2026
Integrating artificial intelligence and manual curation to enhance bioassay annotations in ChEMBL.
Journal: Journal of cheminformatics
Published: September 05, 2025
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.
Journal: Nucleic acids research
Published: September 09, 2023
Decomposing compounds enables reconstruction of interaction fingerprints for structure-based drug screening.
Journal: Journal of cheminformatics
Published: October 14, 2021
Toward an Understanding of Pan-Assay Interference Compounds and Promiscuity: A Structural Perspective on Binding Modes.
Journal: Journal of chemical information and modeling
Published: April 26, 2021
PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA.
Journal: Nucleic acids research
Published: January 29, 2021
Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning.
Journal: International journal of molecular sciences
Published: October 22, 2020
Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor.
Journal: PloS one
Published: March 10, 2020
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs.
Journal: Computational and structural biotechnology journal
Published: November 08, 2019
Structure-based drug repositioning: Potential and limits.
Journal: Seminars in cancer biology
Published: August 01, 2019
PLIP: fully automated protein-ligand interaction profiler.
Journal: Nucleic acids research
Published: January 29, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026